Clinical Trial Update: A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer [Phase 2]

View source ↗

Summary

Phase II randomized study evaluating palbociclib with letrozole as neoadjuvant therapy in ER-positive primary breast cancer; the trial is completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer, Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-01-13